Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by mtvrdonon Mar 06, 2017 3:17pm
71 Views
Post# 25939167

RE:RE:I hope multi-dollars level before taking over

RE:RE:I hope multi-dollars level before taking overI have to disagree on that.   Microsoft is a prime example of a tech company that has bought out many small companies for their technology, well before said companies turned a profit.  

Bigger players are looking for quick ways to add value and differentiate their products from competitors all the time.   One of the big Ultrasound players (some of them being Siemens, Philips, GE,  Toshiba) would absolutely buy this company for the technology because it  let their sales people go in to cardiac facilities with a patented, FDA approved, Health Canada approved value-add proposition that offers a cheaper alternative to MRI. 

Bear in mind that regulatory approvals take quite a while if you are Ventripoint or if you are GE.   If a large player wants to get a jump on the competition, I think they would absolutely buy a proven-FDA tech that gives them a competitive edge and lets them up-sell their existing Ultrasound equipment. 

Ventripoint should obviously still be going to be marketing their product, instead of just waiting for a takeout.   However, they are a definite target IMO.


Bullboard Posts